Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage IV Gastric Cancer”

459 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 459 results

Testing effectiveness (Phase 2)Study completedNCT00767377
What this trial is testing

Continuous Infusion of FU Combined With Epirubicin and Oxaliplatin in Patients With A/MGC

Who this might be right for
Gastric Cancer
Fudan University 163
Testing effectiveness (Phase 2)Study completedNCT00017043
What this trial is testing

BMS-247550 in Treating Patients With Metastatic Stomach Cancer Previously Treated With Chemotherapy

Who this might be right for
Esophageal CancerGastric Cancer
Bristol-Myers Squibb
Early research (Phase 1)Ended earlyNCT02714374
What this trial is testing

GL-ONC1 Administered Intravenously Prior to Surgery to Patients With Solid Organ Cancers

Who this might be right for
Solid Organ Cancers
Andrew Lowy 5
Early research (Phase 1)Study completedNCT01522820
What this trial is testing

Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors

Who this might be right for
Anaplastic AstrocytomaAnaplastic OligoastrocytomaAnaplastic Oligodendroglioma+62 more
Roswell Park Cancer Institute 18
Testing effectiveness (Phase 2)Ended earlyNCT01716546
What this trial is testing

Trial of Panitumumab Cisplatin, Fluourouracil and Docetaxel in Locally Advanced or Metastatic Gastric Cancer

Who this might be right for
Gastric Cancer
Hellenic Oncology Research Group 51
Testing effectiveness (Phase 2)Study completedNCT00002722
What this trial is testing

High-Dose Chemotherapy in Treating Patients With Advanced Stomach Cancer

Who this might be right for
Gastric Cancer
European Organisation for Research and Treatment of Cancer - EORTC 135
Large-scale testing (Phase 3)Not Yet RecruitingNCT07362186
What this trial is testing

LM-108 in Combination With Toripalimab Versus Paclitaxel Injection for the Treatment of Subjects With CCR8-Positive Gastric and Gastroesophageal Junction Adenocarcinoma

Who this might be right for
Locally Advanced or Metastatic GC and GCJ Adenocarcinoma
LaNova Medicines Limited 400
Testing effectiveness (Phase 2)Study completedNCT04694183
What this trial is testing

The Conversion Therapy of Chemotherapy Plus Camrelizumab in Metastatic Gastric Cancer

Who this might be right for
Stomach Neoplasms
Quan Wang 37
Large-scale testing (Phase 3)Study completedNCT02563054
What this trial is testing

Capecitabine (Xeloda) in Participants With Advanced or Metastatic Gastric Cancer

Who this might be right for
Gastric Cancer
Hoffmann-La Roche 316
Early research (Phase 1)Study completedNCT05765357
What this trial is testing

Clinical Study to Compare the Pharmacokinetics and Safety of Trastuzumab for Injection With Herceptin® in Healthy Male Volunteers

Who this might be right for
Metastatic Breast CancerMetastatic Gastric Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 89
Testing effectiveness (Phase 2)Study completedNCT01503983
What this trial is testing

Efficacy and Safety of Trastuzumab, Capecitabine y Oxaliplatine as Treatment Gastric Cancer Metastatic (HER2)Positive

Who this might be right for
Stage IV Gastric Cancer With Metastasis
Fundación para el Progreso de la Oncología en Cantabria 45
Testing effectiveness (Phase 2)UnknownNCT04089657
What this trial is testing

Apatinib Plus Sintilimab in Advanced Gastric Cancer Refractory to at Least Two Previous Chemotherapy Regimens

Who this might be right for
Advanced Metastatic Gastric Cancer
Fujian Cancer Hospital 40
Testing effectiveness (Phase 2)Study completedNCT00004895
What this trial is testing

Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery

Who this might be right for
Colorectal CancerConstipation, Impaction, and Bowel ObstructionExtrahepatic Bile Duct Cancer+7 more
Northwestern University
Early research (Phase 1)Ended earlyNCT06264921
What this trial is testing

A Study With NKT3447 for Adults With Advanced/Metastatic Solid Tumors

Who this might be right for
Solid TumorSolid Tumor, AdultAdvanced Solid Tumor+26 more
NiKang Therapeutics, Inc. 23
Testing effectiveness (Phase 2)Ended earlyNCT00683787
What this trial is testing

Docetaxel With or Without Vandetanib in Treating Patients With Metastatic Stomach Cancer or Gastroesophageal Junction Cancer

Who this might be right for
Gastric Cancer
Roswell Park Cancer Institute 8
Early research (Phase 1)Study completedNCT00553696
What this trial is testing

Study Of Sunitinib With S-1 And Cisplatin For Gastric Cancer

Who this might be right for
Stomach Neoplasms
Pfizer 27
Testing effectiveness (Phase 2)Looking for participantsNCT06008925
What this trial is testing

Clinical Study of VG161 Combined With Nivolumab Injection in Patients With Advanced Metastatic Gastric Cancer

Who this might be right for
Metastatic Gastric Cancer
CNBG-Virogin Biotech (Shanghai) Ltd. 43
Large-scale testing (Phase 3)Not Yet RecruitingNCT07332533
What this trial is testing

KN026-based Combination Therapy in HER2-positive Gastric Cancer

Who this might be right for
HER2-positive Gastric Cancer
Shanghai JMT-Bio Inc. 490
Not applicableLooking for participantsNCT05334069
What this trial is testing

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myeloid LeukemiaAnn Arbor Stage I Lymphoma+59 more
Alliance for Clinical Trials in Oncology 2,000
Early research (Phase 1)UnknownNCT03026881
What this trial is testing

Fluzoparib Given in Combination With Apatinib and Paclitaxel in Gastric Cancer Patients

Who this might be right for
Recurrent and Metastatic Gastric Cancer
Jiangsu HengRui Medicine Co., Ltd. 24
Load More Results